Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery

Journal of Biomaterials Applications

Volumn 26, Issue 8, 2012, Pages 893-916

  Nie, Yu ^a   Zhang, Zhi Rong ^a   He, Bin ^a   Gu, Zhongwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cytotoxicity; expression; gene therapy; in vivo efficacy; interleukin 18; multipolyplexes; nanoparticles

Indexed keywords

ANTI-TUMOR EFFICACY; BALB/C MICE; CELL LINES; CIS-PLATIN; COLON CANCER; EXPRESSION; GENE DELIVERY; GLYCOLIC ACIDS; HEPATOCYTES; HISTOLOGICAL SECTION; IN-VITRO; IN-VIVO; INTERLEUKIN-18; INTRAVENOUS INJECTIONS; MULTIPOLYPLEXES; MYOBLASTS; PHYSICOCHEMICAL PROPERTY; POLY LACTIDE-CO-GLYCOLIDE; POLYCATIONIC PEPTIDES; POLYLYSINE; SURVIVAL CURVES; TUMOR INHIBITION; VASCULAR ENDOTHELIAL CELLS; WESTERN BLOTS;

CELL CULTURE; CHEMOTHERAPY; CYTOTOXICITY; DEGRADATION; ENDOTHELIAL CELLS; ETHYLENE GLYCOL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; LACTIC ACID; MAMMALS; PLATINUM COMPOUNDS; POLYMERS; ZETA POTENTIAL;

NANOPARTICLES;

INTERLEUKIN 18; LACTIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; FEMALE; GENE TRANSFER; GENETICS; HUMAN; MALE; MOUSE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-18; LACTIC ACID; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID;

EID: 84860771674     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328210384889     Document Type: Article

References (54)

1. Huber P.E., Pfisterer P.. In vitro and In vivo Transfection of Plasmid DNA in the Dunning Prostate Tumor R3327-AT1 is Enhanced by Focused Ultrasound. Gene Ther.. 2000 ; 7: 1516-1525
2. Prabha S., Labhasetwar V.. Critical Determinants in PLGA/PLA Nanoparticle-mediated Gene Expression. Pharm. Res.. 2004 ; 21: 354-364 (Pubitemid 38221983)
3. Labhasetwar V., Bonadio J., Goldstein S.A., et al. Gene Transfection Using Biodegradable Nanospheres: Results in Tissue Culture and a Rat Osteotomy Model. Colloid. Surf. B Biointerf.. 1999 ; 16: 281-290 (Pubitemid 29486815)
4. Sorgib F.L., Bhattacharya S., Huang L.. Protamine Sulfate Enhances Lipid-Mediated Gene Transfer. Gene Ther.. 1997 ; 4: 961-968 (Pubitemid 27437722)
5. Tsai J.T., Furstoss K.J., Michnick T., Sloane D.L., Paul R.W.. Quantitative Physical Characterization of Lipid-Polycation-DNA Lipopolyplexes. Biotechnol. Appl. Biochem.. 2002 ; 36: 13-20 (Pubitemid 34864480)
6. Capan Y., Woo B.H., Gebrekidan S., Ahmed S., Deluca P.P.. Influence of Formulation Parameters on the Characteristics of Poly(D,L-lactide-co-glycolide) Microspheres containing Poly(L-lysine) Complexed Plasmid DNA. J. Control. Release. 1999 ; 60: 279-286 (Pubitemid 29335953)
7. Jeong J.H., Park T.G.. Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) Micelles for Low Cytotoxic Biodegradable Gene Delivery Carriers. J. Control. Release. 2002 ; 82: 159-166 (Pubitemid 34775057)
8. Bivas-Benita M., Romeijn S., Junjinger H.E., Borchard G.. PLGA-PEI Nanoparticles for Gene Delivery to Pulmonary Epithelium. Eur. J. Pharm. Biopharm.. 2004 ; 58: 1-6 (Pubitemid 38780998)
9. Patil Y., Panyam J.. Polymeric Nanoparticles for siRNA Delivery and Gene Silencing. Int. J. Pharm.. 2009 ; 367: 195-203
10. Katas H., Cevher E., Alpara H.O.. Preparation of Polyethyleneimine Incorporated Poly(D,L-lactide-co-glycolide) Nanoparticles by Spontaneous Emulsion Diffusion Method for Small Interfering RNA Delivery. Int. J. Pharm.. 2009 ; 369: 144-154
11. Chumakova O.V., Liopo A.V., Andreev V.J., Cicenaite I., Evers B.M., Chakravorty S.. Composition of PLGA and PEI/DNA Nanoparticles Improves Ultrasound-mediated Gene Delivery in Solid Tumors In vivo. Cancer Lett.. 2008 ; 261: 215-225
12. Okamura H., Tsutsi H., Komatsu T., Yutsudu M., Hakura A., Tanimoto T.. Cloning of a New Cytokine that Induces IFN-Gama Production by T-cells. Nature. 1995 ; 378: 88-91
13. Tough D.F., Borrow P., Sprent J.. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon In Vivo. Science. 1996 ; 272: 1947-1950 (Pubitemid 26234507)
14. Tsutsui H., Nakanishi K., Matsui K., et al. Interferon Gamma-inducing Factor (IGIF) Upregulates Fas Ligand-Mediated Cytotoxic Activity of Murine Natural Killer Cell Clones. Hepatology. 1996 ; 24: 1351-1351
15. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H.. Interleukin-18 Regulates Both TH1 and TH2 Responses. Annu. Rev. Immunol.. 2001 ; 19: 423-474 (Pubitemid 32368042)
16. Wigginton J.M., Lee J-K., Wiltrout T.A., Alvora W.G., Hixon J.A., Sublesji J.. Synergistic Engagement of an Ineffective Endogenous Anti-Tumor Immune Response and Induction of IFN-Gamma and Fas-Ligand-Dependent Tumor Eradication by Combined Administration of IL-18 and IL-2. J. Immunol.. 2002 ; 169: 4467-4474 (Pubitemid 35178223)
17. Osaki T., Hashimoto W., Gambotto A., et al. Potent Antitumor Effects Mediated by Local Expression of the Mature Form of the Interferon-Gamma Inducing Factor, Interleukin-18 (IL-18). Gene Ther.. 1999 ; 6: 808-815 (Pubitemid 29243654)
18. Micallef M.J., Tanimoto T., Kohno K., Ikeda M., Kurimoto M.. Interleukin 18 Induces the Sequential Activation of Natural Killer Cells and Cytotoxic T Lymphocytes to Protect Syngeneic Mice from Transplantation with Meth A Sarcoma. Cancer Res.. 1997 ; 57: 4557-4563 (Pubitemid 27441061)
19. Hashimoto W., Osaki T., Okamura H., et al. Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 are Mediated Primarily by Fas-Fas Ligand and Perforin-induced Tumor Apoptosis, Respectively. J. Immunol.. 1999 ; 163: 583-589 (Pubitemid 29328059)
20. Osaki T., Peron J.M., Cai Q., et al. IFN-Gamma-inducing Factor IL-18 Administration Mediates IFN-Gamma- and IL-12-Independent Antitumor Effects. J. Immunol.. 1998 ; 160: 1742-1749 (Pubitemid 28106460)
21. Akamatsu S., Arai N., Hanaya T., et al. Antitumor Activity of Interleukin-18 Against the Murine T-Cell Leukemia/Lymphoma EL-4 in Syngeneic Mice. J. Immunother.. 2002 ; 25: S28 - S34
22. Wang Q., Yu H., Ju D.W., et al. Intratumoral IL-18 Gene Transfer improves Therapeutic Efficacy of Antibody-targeted Superantigen in Established Murine Melanoma. Gene Ther.. 2001 ; 8: 542-550 (Pubitemid 32409529)
23. Ju D.W., Yang Y., Tao Q., et al. Interleukin-18 Gene Transfer Increases Antitumor Effects of Suicide Gene Therapy Through Efficient Induction of Antitumor Immunity. Gene Ther.. 2000 ; 7: 1672-1679
24. Zheng J-N., Pei D-S., Mao L-J., et al. Oncolytic Adenovirus Expressing Interleukin-18 Induces Significant Antitumor Effects Against Melanoma in Mice through Inhibition of Angiogenesis. Cancer Gene Ther.. 2010 ; 17: 28-36
25. Duan Y., Nie Y., Gong T., Wang Q., Zhang Z.. Evaluation of Blood Compatibility of MeO-PEG-poly (D,L-lactic-co-glycolic acid)-PEG-OMe Triblock Copolymer. J. Appl. Polym. Sci.. 2006 ; 100: 1019-1023
26. Sun X., Duan Y.R., He Q., Lu J., Zhang Z.R.. PELGE Nanoparticles as New Carriers for the Delivery of Plasmid DNA. Chem. Pharm. Bull.. 2005 ; 53: 599-603 (Pubitemid 40880246)
27. Nie Y., Zhang Z.R., Duan Y.R.. Combined Use of Polycationic Peptide and Biodegradable Macromolecular Polymer as a Novel Gene Delivery System: A Preliminary Study. Drug Deliv.. 2006 ; 13: 441-446 (Pubitemid 44470224)
28. Nie Y., Yuan W-M., Gong T., Lu J., Fu Y., Zhang Z-R.. Investigation on Characterization and Transfection of a Novel Multi-Polyplex Gene Delivery System. J. Appl. Polym. Sci.. 2007 ; 106: 1028-1033 (Pubitemid 47384084)
29. Jia J., Li H., Li M.Y., et al. Construction of Eukaryotic Expression Vector Containing Mouse IL-18 and Examination of the Bioactivity of the Expressed IL-18. West China J. Pharmaceut. Sci.. 2005 ; 20: 476-480
30. Blanco-Bose W.E., Yao C-C., Kramer R.H., Blau H.M.. Purification of Mouse Primary Myoblasts Based on α 7 Integrin Expression. Exp. Cell Res.. 2001 ; 265: 212-220 (Pubitemid 32980209)
31. Zhang S-Z., Xu Y., Xie H-Q., Li X-Q., Wei Y-Q., Yang Z-M.. The Possible Role of Myosin Light Chain in Myoblast Proliferation. Biol. Res.. 2009 ; 42: 121-132
32. Hasegawa Y., Shimada K., Suzuki N., et al. The In vitro Osteogenetic Characteristics of Primary Osteoblastic Cells from a Rabbit Calvarium. J. Oral Sci.. 2008 ; 50: 427-434
33. Ballermann B.J.. Regulation of Bovine Glomerular Endothelial Cell Growth In Vitro. Am. J. Physiol.. 1989 ; 256: C182-189
34. Lozonschi L., Sunamura M., Kobari M., Egawa S., Ding L., Matsuno S.. Controlling Tumor Angiogenesis and Metastasis of C26 Murine Colon Adenocarcinoma by a New Matrix Metalloproteinase Inhibitor, KB-R7785, in Two Tumor Models. Cancer Res.. 1999 ; 59: 1252-1258 (Pubitemid 29136255)
35. Chang C.W., Choi D., Kim W.J., et al. Non-Ionic Amphiphilic Biodegradable PEG-PLGA-PEG Copolymer Enhances Gene Delivery Efficiency in Rat Skeletal Muscle. J. Control. Release. 2007 ; 118: 245-253 (Pubitemid 46331900)
36. Ribeiro S., Rijpkema S.G., Durrani Z., Florence A.T.. PLGA-Dendron Nanoparticles Enhance Immunogenicity but not Lethal Antibody Production of a DNA Vaccine against Anthrax in Mice. Int. J. Pharm.. 2007 ; 331: 228-232 (Pubitemid 46223618)
37. Zhao D., Gong T., Fu Y., et al. Lyophilized Cheliensisin A Submicron Emulsion for Intravenous Injection: Characterization, In vitro and In vivo Antitumor Effect. Int. J. Pharm.. 2008 ; 357: 139-147
38. Duan Y., Xu S., Wang Q., Liu J., Zhang Z.. Optimization of Preparation of DHAQ-loaded PEG-PLGA-PEG Nanoparticles Using Central Composite Design. J. Mater. Sci. Mater. Med.. 2006 ; 17: 559-563 (Pubitemid 43725243)
39. He L., Yang L., Zhang Z-R., et al. In vitro Evaluation of the Genotoxicity of a Family of Novel MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe Triblock Copolymer and PLGA Nanoparticles. Nanotechnology. 2009 ; 20: 455102
40. Duan Y., Zhang Y., Gong T., Zhang Z.. Synthesis and Characterization of MeO-PEG-PLGA-PEG-OMe Copolymers as Drug Carriers and their Degradation Behavior In vitro. J. Mater. Sci. Mater. Med.. 2007 ; 18: 2067-2073 (Pubitemid 47421885)
41. Liu H., Slamovich E.B., Webster T.J.. Less Harmful Acidic Degradation of Poly(lacticco-glycolic acid) Bone Tissue Engineering Scaffolds through Titania Nanoparticle Addition. Int. J. Nanomed.. 2006 ; 1: 541-545
42. Sasatsu M., Onishi H., Machida Y.. In vitro and In vivo Characterization of Nanoparticles made of MeO-PEG amine/PLA Block Copolymer and PLA. Int. J. Pharm.. 2006 ; 317: 167-174
43. Esmaeili F., Ghahremani M.H., Esmaeili B., Khoshayand M.R., Atyabi F., Dinarvand R.. PLGA Nanoparticles of Different Surface Properties: Preparation and Evaluation of their Body Distribution. Int. J. Pharm.. 2008 ; 349: 249-255 (Pubitemid 350299701)
44. Kuwahara T., Asanami S., Kawauchi Y., Kubo S.. Experimental Infusion Phlebitis: Tolerance pH of Peripheral Vein. J. Toxicol. Sci.. 1999 ; 24: 113-121 (Pubitemid 29252183)
45. Fantuzzi G., Dinarello C.A.. Interleukin-18 and Interleukin-1 Beta: Two Cytokine Substrates for ICE (caspase-1). J. Clin. Immunol.. 1999 ; 19: 1-11 (Pubitemid 29113328)
46. Gu Y., Kuida K., Tsutsui H., et al. Activation of Interferon- Inducing Factor Mediated by Interleukin-1? Converting Enzyme. Science. 1997 ; 275: 206-209 (Pubitemid 27034760)
47. O'Donovan L.H., McMonagle E.L., Taylor S., Argyle D.J., Nicolson. L.. Bioactivity and Secretion of Interleukin-18 (IL-18) Generated by Equine and Feline IL-18 Expression Constructs. Vet. Immunol. Immunopathol.. 2004 ; 102: 421-428 (Pubitemid 39487234)
48. Cuenca A.G., Jiang H., Hochwald S.N., Delano M., Cance W.G., Grobmyer S.R.. Emerging Implications of Nanotechnology on Cancer Diagnostics and Therapeutics. Cancer. 2006 ; 107: 459-466 (Pubitemid 44107204)
49. Hobbs S.K., Monsky W.L., Yuan F., et al. Regulation of Transport Pathways in Tumor Vessels: Role of Tumor Type and Microenvironment. Proc. Natl Acad. Sci. USA. 1998 ; 95: 4607-4612 (Pubitemid 28207960)
50. Sandanaraj B.S., Gremlich H-U., Kneuer R., Dawson J., Wacha S.. Fluorescent Nanoprobes as a Biomarker for Increased Vascular Permeability: Implications in Diagnosis and Treatment of Cancer and Inflammation. Bioconjugate Chem.. 2010 ; 21: 93-101
51. Song C.K., Han H.D., Noh K.H., et al. Chemotherapy Enhances CD8(+) T Cell-mediated Antitumor Immunity Induced by Vaccination with Vaccinia Virus. Mol. Ther.. 2007 ; 15: 1558-1563 (Pubitemid 47099313)
52. Naglieri E., Procacci A., Galetta D., Abbate I., Dell'Erba L., Colucci G.. Cisplatin, Interleukin-2, Interferon-alpha and Tamoxifen in Metastatic Melanoma. A Phase II Study. J. Chemother.. 1999 ; 11: 150-155 (Pubitemid 29198098)
53. Zagozdzon R., Stoklosa T., Golab J., et al. Augmented Antitumor Effects of Combination Therapy with Interleukin-12, Cisplatin, and Tumor Necrosis Factor-Alpha in a Murine Melanoma Model. Anticancer Res.. 1997 ; 17: 4493-4498 (Pubitemid 28081733)
54. Loeffler M., Le'Negrate G., Krajewska M., Reed J.C.. IL-18-Producing Salmonella Inhibit Tumor Growth. Cancer Gene Ther.. 2008 ; 15: 787-794